Can an HIV drug beat COVID?
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
On Monday, China's drug regulator (NMPA) conditionally approved a domestically made HIV drug for treating COVID-19 patients.
Some context: The drug, Azvudine, produced by Zhengzhou-based Genuine Biotech, was originally approved for treating HIV-1 infections in July 2021.
Monday's approval mak...